Copy and paste this code to insert a reference to this article in your
blog or online community profile:
A Prospective, Single-Center, Randomized Phase 2 Trial of Etoposide in Severe COVID-19
J Infect Dis Ther. 0:0, (2023)
https://doi.org/10.4173/2332-0877.23.S4.001
Highlight
Will Display Like this:
A Prospective, Single-Center, Randomized Phase 2 Trial of Etoposide in Severe COVID-19
J Infect Dis Ther. 0:0, (2023)
https://doi.org/10.4173/2332-0877.23.S4.001
Powered by
OMICS International